Theratome Bio, Inc. — Form D
Theratome Bio, Inc. of Houston, TX, a company, filed a Form D exempt-offering notice with the SEC on 2016-04-04. The offering totals $3.5M, of which $1.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-04-04
- Form: D
- Accession: 0001671248-16-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.5M
- Amount sold: $1.9M
- Remaining: $1.6M
- Minimum investment: $40K
- Investors: 6
- Date of first sale: 2016-02-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-260600
Issuer
- Name: Theratome Bio, Inc.
- CIK: 0001671248
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 9128 Lakes at 610 Drive, Houston, TX, 77054
- Phone: 8324525117
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Scott A Jones | Director | Fishers, IN |
| Keith L March | Director | Fishers, IN |
| Brad L Miller | Director | Fishers, IN |
| Wade Lange | Executive Officer | West Lafayette, IN |
| Jennifer Rhodes | Executive Officer | Noblesville, IN |
| Michael T Redman | Director | Houston, TX |
| Michael T Redman | Executive Officer | Houston, TX |
| James Donald Payne | Executive Officer | Houston, TX |
| Keith T March MD PhD | Director | Houston, TX |
| Keith T March MD PhD | Executive Officer | Houston, TX |
| Brad T Miller | Director | Houston, TX |
| Michael Donald Trotta | Director | Houston, TX |
Other filings by this issuer (1)
More